Reuters: Regulatory News: UPDATE 1-U.S. FDA warns Zimmer over manufacturing of hip devices

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

UPDATE 1-U.S. FDA warns Zimmer over manufacturing of hip devices Oct 1st 2012, 21:56 Mon Oct 1, 2012 5:56pm EDT Oct 1 (Reuters) - Zimmer Holdings Inc said it received a warning letter from the U.S. Food and Drug Administration citing problems with manufacturing and testing processes for artificial hip devices made at the company's Ponce, Puerto Rico, plant. The warning letter, dated Sept. 19, does not restrict production or shipment of the hip devices, called Trilogy Acetabular Systems, or require withdrawal of any products from the market, Zimmer said in a regulatory filing. The FDA said Zimmer failed to implement a testing mechanism to demonstrate the products met certain design specifications and had not validated the effects of manufacturing operations on products that incorporate metallic spikes. The warning follows a June inspection of the company's Ponce plant. Zimmer said it temporarily suspended release of the affected products and has since completed the validation process for Trilogy products that do not incorporate metallic spikes. The company expects to complete validation of Trilogy spiked products within the next few weeks.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions